Digirad Corporation (NASDAQ: DRAD) Investor Investigation Concerning Potential Securities Laws Violations Announced

Investors who purchased shares of Digirad Corporation (NASDAQ: DRAD), have certain options and should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Digirad
Affected Securities: 
NASDAQ: DRAD

An investigation on behalf of investors of Digirad Corporation (NASDAQ: DRAD) shares over potential securities laws violations by Digirad and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Digirad Corporation (NASDAQ: DRAD) concerning whether a series of statements by Digirad Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Suwanee, GA based Digirad Corporation provides healthcare solutions in the United States.
Digirad Corporation reported that its annual Total Revenue declined from $125.46 million in 2016 to $118.33 million in 2017 and that its Net Income of $14.3 million in 2016 turned into a Net Loss of $35.73 million in 2017.

Shares of Digirad Corporation (NASDAQ: DRAD) declined from $6.05 per share in October 2015 to as low as $1.25 per share in early April 2018.